Reprint

Chronic Kidney Disease: Underlying Molecular Mechanisms

Edited by
August 2023
216 pages
  • ISBN978-3-0365-8541-3 (Hardback)
  • ISBN978-3-0365-8540-6 (PDF)

This book is a reprint of the Special Issue Chronic Kidney Disease: Underlying Molecular Mechanisms that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Chronic kidney disease (CKD) is a worldwide public health problem that must be addressed. The global increase in CKD prevalence is associated with an increase in conventional disease risk factors (e.g., diabetes and hypertension), which may be exacerbated by additional variables such as environmental and occupational exposure to toxic compounds. Authors contributed to this Special Issue by highlighting the finding of potential novel biomarkers of the disease and more effective therapy alternatives, as well as works that enhance the understanding of CKD pathogenesis and its related complications.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
kidney; lymphatics; sodium; NKCC1 transporter; CKD; inflammation; TNF-alpha; TNFR; biomarkers; chronic kidney disease; hypertension; children; short-chain fatty acids; developmental origins of health and disease (DOHaD); gut microbiota; probiotics; prebiotics; trimethylamine-N-oxide; chronic kidney disease; short-chain fatty acids; oxidative stress; inflammation; uremic toxins; TRPC6; UUO; NZO mice; inflammation; fibrosis; CKD; SH045; chronic kidney disease; heavy metals; cadmium; mercury; arsenic; cellular injury; urine proteome; FSGS; MCD; podocyte dysfunction; mass spectrometry; chronic kidney disease; growth hormone; cachexia; lipolysis; adipose tissue browning; muscle mass; muscle function; chronic kidney disease; skeletal muscle wasting; reactive oxygen species (ROS); oxidative stress; exercise; Marinobufagenin (MBG); chronic kidney disease; end-stage renal disease (ESRD); nervous and immune systems; n/a